TO THE EDITOR
The phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway plays an important role in the proliferation, differentiation and survival of hematopoietic cells. 1 Recently, it was found that Akt was phosphorylated and activated in the majority of primary acute myeloid leukemia (AML) cells, and that constitutive activation of the PI3K/Akt pathway is necessary for the survival of AML cells. 2, 3 In addition, constitutive phosphorylation of Akt was associated with poor prognosis of AML. 3 Although phosphorylation and activation of Akt is used as an indicator of PI3K activation, a recent study demonstrated that Akt was activated by a PI3K-independent mechanism. 4 Since PI3K activity in primary AML cells has not yet been analyzed in previous studies, 2, 3 we examined PI3K activity and phosphorylation of Akt in primary AML cells and the function of PI3K in the proliferation of leukemia cells.
To address the involvement of PI3K in the proliferation of the leukemia cells from 40 patients with AML (M0, 2; M1, 5; M2, 11; M3, 3; M4, 8; M5, 7; M6, 3; M7, 1), we performed an in vitro PI3K and 3 H-thymidine incorporation assays as described previously, 5, 6 after obtaining informed consent from the patients. PI3K was constitutively activated in 21 (52.5%) of 40 AML cases (Table 1 and Figure 1a ). The frequency of constitutive activation of PI3K in spontaneously proliferating AML cells was significantly higher than that in AML cells that did not proliferate spontaneously in the absence of cytokines (GM-CSF, G-CSF, stem cell factor and thrombopoietin) (72.2% (13/18) vs 36.4% (8/22), Fisher exact test, Po0.05). In addition, stronger PI3K activity in AML cells was associated with a higher rate of spontaneous proliferation of the cells (Po0.05). The expression of p85a, a regulatory subunit of PI3K, was detected in all of the 32 cases analyzed by Western blotting using anti-p85a antibody (Upstate, Charlottesville, VA, USA) (data not shown), although its expression was detected in only seven of 14 AML cases in the previous study. 3 We next analyzed the phosphorylation of Akt on Thr308 (pThr308) and Ser473 (pSer473) in 25 cases, including 13 with and 12 without constitutive activation of PI3K, by Western blotting using phospho-Akt antibodies (New England Biolabs, Beverly, MA, USA) ( Table 1 and Figure 1b) . The pThr308 and pSer473 was detected in all of the 13 AML cases with activated PI3K. PI3K activation significantly correlated with the pThr308 and pSer473 (Po0.01). Interestingly, Akt was constitutively phosphorylated on Thr308 and Ser473 in one case with M1 (case 5) without activated PI3K. Moreover, Min et al 3 found that the phosphorylation of Akt on Thr308 and Ser473 in AML cells was significantly but not completely inhibited by LY294002, a selective inhibitor of PI3K. These findings suggest that the PI3K-independent pathway is involved in Akt activation in AML cells.
Next, we examined the inhibitory effect of LY294002 on the spontaneous proliferation of leukemia cells from 17 AML cases. LY294002 dose-dependently inhibited the spontaneous prolif-eration of AML cells from 12 cases with activated PI3K with less than 5 mM of the 50% inhibitory concentration (IC 50 ) ( Table 1 and Figure 1c ). IC 50 was 25.5-38 mM of LY294002 in five cases without activated PI3K. AML cells with activated PI3K were more sensitive to cytotoxicity by LY294002 compared to cells without PI3K activation (Po0.01). In addition, the antisense oligonucleotide (AS-ODN) against p85a inhibited the spontaneous proliferation of leukemia cells from one case with M4 (case 23) (Figure 1d) .
We have demonstrated that the constitutive activation of PI3K in AML cells was significantly associated with Akt phosphorylation and the spontaneous proliferation of leukemia cells. One of the mechanisms of constitutive activation of PI3K is the expression of internal tandem duplication of Flt3 (Flt3 ITD) in AML cells. 2, 7 However, the finding that Akt was activated in eight of nine AML cases in which Flt3 ITD was not detected 2 indicates that another mechanism such as interaction of the Ras/MAPK pathway with PI3K may play a role in constitutive activation of PI3K. 8 In addition, recent studies demonstrated the mutations and hemizygous deletions of phosphatase and tensin homolog deleted on chromosome 10 (PTEN), and the dominant-negative mutation of SH2-containing inositol 5-phosphatase (SHIP) in AML cells, 1 suggesting that PI3K may be dysregulated by the loss of function of these phosphatases, which are negative regulators of the PI3K pathway. Our findings in the present study suggest that a PI3K-independent mechanism plays a role in Akt phosphorylation in AML cases. Recently, it was found that p38-MAPK was involved in Akt phosphorylation in human mammary epithelial cells. 4 Further studies are required to elucidate the molecular mechanism of constitutive phosphorylation of Akt by the PI3K-independent pathway in AML cells. Furthermore, because normal CD34-positive cells are resistant to a PI3K inhibitor compared to AML cells, 2 the PI3K/Akt pathway is a potential target for AML therapy. H-thymidine incorporation assay as described previously. 6 The cells were incubated with various concentrations of LY294002 (0.1-50 mM) or dimethyl sulfoxide as a control in triplicate. After 36 h of culturing, 1 mCi 3 H-thymidine was added to each well 4 h prior to cell harvest. Normal resting T cells in the peripheral blood were also used as a control to determine whether AML cells proliferated spontaneously. The relative amount of radioactivity of AML cells without spontaneous proliferating activity was less than twice as large as that of resting T cells. 0 -ATGAGTGCTGAGGGGTACCAGTAC-3 0 , respectively, as described previously. H-thymidine incorporation assay was performed for analysis of the proliferation of AML cells. The numbers shown represent the relative amount of radioactivity of AML cells compared with that of resting T cells as a control. AML cells without spontaneously proliferating activity had less than twice the level of radioactivity compared with that of resting T cells. The radioactivity of resting T cells was less than 500 cpm. The numbers shown represent the percentage of PI3K activity in each aPY immunoprecipitate from lysates of AML cells compared with that from K562 cells. The percentage of PI3K activity in each aPY immunoprecipitate from lysates of AML cells without activated PI3K was less than 15% of that from K562 cells.
